Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Cathryn M. Bennett"'
Autor:
Evan Rosenbaum, Rashmi Chugh, Christopher W. Ryan, Mark Agulnik, Mohammed M. Milhem, Suzanne George, Robin L. Jones, Bartosz Chmielowski, Brian A. Van Tine, Hussein Tawbi, Anthony D. Elias, William L. Read, G. Thomas Budd, Li-Xuan Qin, Eve T. Rodler, Joe Hirman, Paul Weiden, Cathryn M. Bennett, Philip O. Livingston, Govind Ragupathi, David Hansen, Sandra P. D'Angelo, William D. Tap, Gary K. Schwartz, Robert G. Maki, Richard D. Carvajal
Publikováno v:
European journal of cancer (Oxford, England : 1990). 176
Recurrence after resection of metastatic sarcoma is common. The gangliosides GM2, GD2 and GD3 are strongly expressed across sarcoma subtypes. We hypothesised that generation of anti-ganglioside antibodies would control micrometastases and improve out
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e267f10138144443e4c5ba401e8b3c65
https://pubmed.ncbi.nlm.nih.gov/36215947
https://pubmed.ncbi.nlm.nih.gov/36215947
Autor:
David Hansen, Bartosz Chmielowski, G. Thomas Budd, Mark Agulnik, Gary K. Schwartz, Suzanne George, Joe Hirman, Christopher W. Ryan, Anthony D. Elias, Rashmi Chugh, Robin L. Jones, Cathryn M. Bennett, Philip O. Livingston, Paul L. Weiden, Richard D. Carvajal, William L. Read, Brian A. Van Tine, Hussein Tawbi, Robert G. Maki, Mohammed M. Milhem
Publikováno v:
Journal of Clinical Oncology. 32:10520-10520
10520 Background: Recurrence after resection of metastatic sarcoma is common. The gangliosides GM2, GD2 and GD3 are strongly expressed on many sarcomas. The generation of anti-ganglioside antibodie...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b8c21c4dad1871a2e6fc41114e64d6b
https://doi.org/10.1200/jco.2014.32.15_suppl.10520
https://doi.org/10.1200/jco.2014.32.15_suppl.10520
Autor:
Mark Agulnik, Brian A. Van Tine, Suzanne George, Christopher W. Ryan, Bartosz Chmielowski, G. Thomas Budd, Anthony D. Elias, Rashmi Chugh, Richard D. Carvajal, Hussein Tawbi, Robert G. Maki, Sujana Movva, Eve T. Rodler, Gary K. Schwartz, Cathryn M. Bennett, William D. Tap, Mary Louise Keohan, Martee L. Hensley, Mohammed M. Milhem, Mark A. Dickson
Publikováno v:
Web of Science
TPS10103 Background: The gangliosides GM2, GD2, and GD3 are strongly expressed in sarcoma and represent novel antitumor targets. We have demonstrated the safety and immunogenicity of individual monovalent ganglioside conjugate vaccines when administe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d915ea9ed280644ea555f189bdec02e0
https://publons.com/wos-op/publon/12756454/
https://publons.com/wos-op/publon/12756454/
